Skip to main content

Table 1 Baseline characteristics of participants

From: Relationship between the non-HDLc-to-HDLc ratio and carotid plaques in a high stroke risk population: a cross-sectional study in China

Characteristic

non-HDLc/HDLc (tertile)

F/x2

P

T1

(n = 287)

T2

(n = 286)

T3

(n = 266)

Male

137 (47.7)

148 (51.8)

170 (63.9)

15.629

< 0.001

Age (years)

64.8 ± 10.0

63.2 ± 9.4

62.7 ± 10.2

3.575

0.028

BMI (kg/m2)

25.54 ± 3.63

25.81 ± 2.99

26.05 ± 3.20

1.612

0.200

SBP (mmHg)

140.08 ± 15.55

140.91 ± 13.34

139.80 ± 16.01

0.411

0.663

DBP (mmHg)

86.87 ± 9.17

87.99 ± 8.78

87.38 ± 9.62

1.051

0.350

FBG (mmol/L)

6.27 ± 1.87

6.41 ± 2.03

6.84 ± 2.48

5.208

0.006

TG (mmol/L)

1.13 (0.84–1.42)

1.54 (1.19–2.00)

2.25 (1.60–3.00)

2.348

< 0.001

TC (mmol/L)

4.27 ± 0.82

4.78 ± 0.78

5.22 ± 0.92

88.790

< 0.001

LDLc (mmol/L)

2.14 ± 0.58

2.70 ± 0.67

2.93 ± 0.81

96.581

< 0.001

HDLc (mmol/L)

1.56 ± 0.35

1.25 ± 0.22

1.03 ± 0.19

287.603

< 0.001

non-HDLc (mmol/L)

2.71 ± 0.64

3.53 ± 0.59

4.19 ± 0.78

337.441

< 0.001

non-HDLc/HDLc

1.78 ± 0.41

2.84 ± 0.29

4.10 ± 0.61

1810.918

< 0.001

HCY (μmol/L)

9.0 (6.0–13.0)

9.5 (7.0–12.4)

9.3 (6.5–13.0)

2.350

0.422

Urban

179 (62.4)

147 (51.4)

102 (38.4)

31.908

< 0.001

Education

   

18.664

0.005

 Primary school or under

125 (43.6)

101 (35.3)

81 (30.5)

  

 Middle or high school

132 (45.9)

157 (54.9)

152 (57.1)

  

 College or above

14 (4.9)

18 (6.3)

26 (9.8)

  

 Not reported

16 (5.6)

10 (3.5)

7 (2.6)

  

Employment status

   

9.479

0.050

 Unemployed

81 (28.2)

95 (33.2)

107 (40.2)

  

 Employed

169 (58.9)

158 (55.3)

135 (50.8)

  

 Not reported

37 (12.9)

33 (11.5)

24 (9.0)

  

Overweight

131 (45.6)

132 (46.2)

137 (51.5)

2.303

0.316

Smoking

96 (33.5)

117 (40.9)

129 (48.5)

12.948

0.002

Lack of exercise

156 (54.4)

163 (57.0)

143 (53.8)

0.671

0.715

Family history of stroke

60 (20.9)

62 (21.7)

54 (20.3)

0.159

0.924

History of stroke

67 (23.3)

60 (21.0)

49 (18.4)

2.019

0.364

History of TIA

13 (4.5)

17 (5.9)

9 (3.4)

2.053

0.358

Heart diseases

79 (27.5)

65 (22.7)

60 (22.6)

2.447

0.294

Hypertension

260 (90.6)

248 (86.7)

227 (85.3)

3.827

0.148

Type 2 diabetes

81 (28.2)

83 (29.0)

92 (34.6)

3.092

0.213

Current antilipidaemic medication

31 (10.8)

26 (9.1)

32 (12.0)

1.273

0.529

High HCY

42 (14.6)

39 (13.6)

50 (18.8)

3.103

0.212

Carotid plaques

108 (37.6)

108 (37.8)

125 (47.0)

6.509

0.039

  1. T1, non-HDLc/HDLc: 0.41–2.35; T2, non-HDLc/HDLc: 2.36–3.36; T3, non-HDLc/HDLc: 3.37–5.98. Continuous data are shown as the mean ± standard deviation or median (interquartile), and categorical data are shown as n (%). For categorical variables, P value was calculated by χ2 or Fisher’s exact test. For continuous variables, P value was calculated by one-way ANOVA or Kruskal–Wallis test
  2. BMI body mass index, SBP systolic pressure, DBP diastolic pressure, FBG fasting blood glucose, TG triglyceride, TC total cholesterol, LDLc low-density lipoprotein cholesterol, HDLc high-density lipoprotein cholesterol, non-HDLc non-high-density lipoprotein cholesterol, HCY homocysteine
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X